Gyre Therapeutics Inc. (GYRE) — Cash Flow Reinvestment Rate
Gyre Therapeutics Inc. (GYRE) has a Cash Flow Reinvestment Rate of 0.96x as of March 2026, reinvesting $3.06 Million (capex $178.00K plus investments $-2.88 Million) from operating cash flow of $3.18 Million. See how much free cash does Gyre Therapeutics Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Gyre Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see GYRE operating cash flow.
Annual Cash Flow Reinvestment Rate for Gyre Therapeutics Inc. (2007–2025)
Year-by-year capital reinvestment analysis for Gyre Therapeutics Inc.. See Gyre Therapeutics Inc. financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.58x | $2.61 Million | $1.01 Million | $1.19 Million | ▲ +136.0% |
| 2023 | 1.09x | $28.35 Million | $25.89 Million | $8.59 Million | ▼ -37.9% |
| 2022 | 1.76x | $18.81 Million | $10.68 Million | $5.00 Million | ▲ +7259.4% |
| 2010 | 0.02x | $3.31 Million | $138.30 Million | $3.31 Million | ▼ -88.0% |
| 2007 | 0.20x | $4.94 Million | $24.84 Million | $4.94 Million | — |